All the below links and tweets are in English.
Germany Vol.22 (pharmaceutical corporations: Bayer, Boehringer Ingelheim) 製薬会社
Germany Vol.21 (pharmaceutical corporations: Merck) 製薬会社
Germany Vol.20 (pharmaceutical corporations: Fresenius, STADA) 製薬会社
Germany Vol.19 (Auswartiges Amt) 外交
Germany Vol.18 (Bundesbank, GTAI, etc.) 中央銀行、貿易等
.@Bayer has filed its prostate cancer drug #darolutamide with Japanese regulators, in an attempt to ratchet up the pressure on rivals Johnson & Johnson and Pfizer/Astellas https://t.co/bQctr3VxMs #pharmanews #oncology pic.twitter.com/GLUlkJqTEQ
— pharmaphorum (@pharmaphorum) March 8, 2019
https://twitter.com/KateMHayes/status/1177660020655378437
A beautiful morning in Leverkusen for Bayer results press conference. And they have a Japanese garden!!who knew?! $BAYRY pic.twitter.com/gVy0XcYfUn
— Amy Brown (@ByAmyBrown) February 27, 2019
Yesterday morning at #BBHIC2019 conference $BLUSF $BLU.TO CEO @rbellini mentioned their drug with 3 competitors $MRK Bayer & Japanese Shionogi
Today I found Shinogi Ph2 results with good efficacy like MRK validating P2X3 antagonism in Chronic-Cough but still with stil with SAE. pic.twitter.com/ZYGSpWcT5P— Joe (@GantosJ) May 2, 2019
Unique Hair Testing Project Reveals High Levels of #Glyphosate in Members of the Japanese Parliament. #Japan #News @Bayer https://t.co/A0FyS3Tkdj
— A Voice For Choice Advocacy (@avoiceforchoice) September 2, 2019
I guess I shouldn't be surprised @Bayer was sponsoring Japanese sports teams then, exactly the way they sponsor Islamic sports teams today. pic.twitter.com/J1DwJ97CKk
— Book of Katherine (@bookofkatherine) April 17, 2020
German side RB Leipzig has apologised after some Japanese fans were reportedly ejected from Sunday's match against Bayer Leverkusen due to fears about the spread of coronavirus https://t.co/QE9HZ7unZg
— RTÉ News (@rtenews) March 2, 2020
You have stock in Bayer, don't you.
Meanwhile, Japanese antiviral favipiravir showing clear benefit for COVID-19 in clinical trials. https://t.co/yghqgI5jYX— 2020- the last year that counts (@PauseListnCount) March 21, 2020
https://twitter.com/Boehringer_AH/status/1192441707578712065
A discovery deal with Boehringer gives Japanese biotech Prism its second large biopharma partner. Prism has a library of peptide mimetics to disrupt protein-protein interactions https://t.co/kDMjgzjBk4
— BioCentury (@BioCentury) June 12, 2020
$HZNP buys ex-North America, Japan rights to interferon gamma-1b from Boehringer Ingelheim: https://t.co/yBYFgKOjY8
— Genetic Engineering & Biotechnology News (@GENbio) May 19, 2016
Mark your calendars and join IPC in Aomori, Japan for #JSID2019 where IPC’s expert faculty will present “Dissecting psoriasis: Mechanistic studies in #pustular and #plaque #psoriasis.”
Agenda: https://t.co/vf4Alg7pYk
This program is sponsored in part by Boehringer-Ingelheim. pic.twitter.com/e1SWOJd4ma
— International Psoriasis Council (@IpcPs) September 27, 2019
https://twitter.com/catvetsusan/status/908713152791109632
Japanese regulators hand first global approval to AbbVie, Boehringer Ingelheim's IL-23 inhibitor Skyrizi https://t.co/k4vMslrwwV $ABBV
— FirstWord Pharma (@fwpharma) March 26, 2019
Boehringer Workforce Dwindles by 500 in Japan, MSD by 300: Jiho Survey Nippon Boehringer Ingelheim, BI’s Japan pharma unit, shed the number of its employees by 500 in a ye… https://t.co/mBpx7hBiBG
— Better medical news and information Better health (@medinfoa2z) May 7, 2019
Boehringer’s Japan Pharma Sales on Course for Recovery; Jardiance, Spiolto Upbeat After suffering a near-20% dip in its drug sales in 2018, Nippon Boehringer Ingelheim has been showi… https://t.co/OVDZkuIn9e
— Better medical news and information Better health (@medinfoa2z) June 7, 2019
Whole Boehringer Ingelheim family, more than 40,000 employees, identifies closely at this moment with our colleagues in Japan.
— Boehringer España (@BoehringerES) March 14, 2011
China halts anti-dumping probe into EU, Japan dialysis kit makers http://t.co/l7rIpNF5wt via @reuters
— Fresenius (@Fresenius) December 17, 2014
Japan's Takeda Pharma says it is developing coronavirus drug #Covid_19 #Takeda #Pharmaceuticals #coronavirus_drug #Stada https://t.co/RrMd6yM6XR
— Susanne Henke | Translations (@LanguageGap) March 5, 2020
Foreign investors continue to target Vietnam’s pharmaceutical industry #Vietnam #pharmaceutical #Abbott #US #Nipro #Taisho #Stada #Germany #Japan #VDSChttps://t.co/vY6pTfGwpl pic.twitter.com/UmulgdUh5J
— Hanoitimes (@Hanoitimes2) January 4, 2020
Scooplet w/@ManuBaigorri — The Japanese company is in advanced talks to sell over-the-counter and prescription-drug assets in Russia to Stada, the German pharmaceutical firm owned by Cinven & Bain — people https://t.co/i6F4BpYxdM
— Sarah M. Syed (@SarahMSyed) October 11, 2019
Japanese pharmaco Takeda is negotiating to sell Russia/Mid East businesses to Germany's Stada Arzneimittel and Swiss Acino International AGhttps://t.co/gPcjQKeDON
— Pernille Rudlin/Rudlin Consulting (@pernilleru) October 11, 2019
Japan's PeptiDream to work with Merck in developing COVID-19 therapies https://t.co/GzIqX0LbZQ pic.twitter.com/T8MxO4ZuZu
— Reuters (@Reuters) June 12, 2020
So glad that Merck's Japanese arm said it will discuss a possible clinical trial of the widely available/affordable drug #Ivermectin in the treatment of #COVID-19 with Kitasato University (also in Japan) https://t.co/ykiBhp46Vv
— Amy Proal, PhD (@microbeminded2) May 8, 2020
Merck gets Japanese nod for TEPMETKO(tepotinib) for non-small cell lung cancer #merck #tepmetko #tepotinib #non-small-cell-lung-cancer https://t.co/4GakUk8tFg
— Medical Dialogues (@medicaldialogs) March 28, 2020
Meet Chifumi Umeda: a high-rope-walking rock music enthusiast who trekked the snow-covered mountains of Japan – all while overseeing one of our company’s largest businesses. Learn more about her journey and what she says is her biggest challenge yet – leading during #COVID19.
— Merck (@Merck) August 5, 2020
AstraZeneca and MSD’s Selumetinib Receive MHLW’s Orphan Drug Designation for Neurofibromatosis Type 1 in Japan @AstraZeneca @Merck https://t.co/azsnR93iP5 pic.twitter.com/34oe5UGj9p
— PharmaShots – Incisive news in 3 shots (@Pharmashot) June 30, 2020
Merck’s Keytruda(pembrolizumab) Receives 5 Approvals from PMDA, Japan across 3 indications @Merck https://t.co/s0dT33LFiY pic.twitter.com/BdXnt7RmYj
— PharmaShots – Incisive news in 3 shots (@Pharmashot) January 4, 2019
https://twitter.com/GHITFund/status/1186920829046493186
Japanese Regulators Approve @Promega CDx for @Merck's #Keytruda https://t.co/KHHHDTWIWG
— GenomeWeb Daily News (@DailyNewsGW) February 6, 2019
Japan Prize / Merck-Banyu Lectureship for Naoya Kumagai / DECHEMA Prize for Timothy Noeel (News) https://t.co/npKfaLlQBg pic.twitter.com/6Q1xQyXK11
— Angewandte Chemie (@angew_chem) April 26, 2018
Merck Receives Fast-Track Designation for Tepotinib in Non-Small Cell Lung Cancer in Japan https://t.co/b7oxZ88NAp @merck_de @merckgroup
— BIO Deutschland (@BIODeutschland) March 27, 2018
See how Germany-based Merck operates a pigment #manufacturing plant in #Japan to develop innovative new products https://t.co/Cu0DUDN20Y
— The Gov't of Japan (@JapanGov) January 22, 2016
See how Germany-based Merck operates a pigment #manufacturing plant in #Japan to develop innovative new products https://t.co/bN1T2LCHhJ
— japan (@japan) January 22, 2016
#Japan Approves #Merck #Keytruda for Non-Small Cell #LungCancerhttps://t.co/UnQKxXqNTA pic.twitter.com/MCJnbU2k5Q
— Pharm Processing (@PharmProcessing) December 20, 2016
Hats off to all the American companies that are pitching in to help Japan recover from Typhoon Hagibis. Among them are @united, @Merck, @abbvie, and @KEEN. Oregon Governor Brown and I met with representatives of @KEEN_Japan to extend our appreciation. pic.twitter.com/v2ieUTdmvC
— ジョセフ・M・ヤング 駐日米国臨時代理大使 (@USAmbJapan) November 21, 2019
MSD Japan Chief Wants Talks with Govt, Re-Pricing Rules Revisited to Help Innovation Thrive Jannie Oosthuizen, Japan chief of US Merck, is calling for price policy discussions with the governm… https://t.co/FOZ3WntTFB
— Better medical news and information Better health (@medinfoa2z) August 7, 2020
> An Australian drug known as Ivermectin
Nice work, NewsMax (sarcasm).#Ivermectin was discovered by a Japanese scientist (won him the Nobel prize!) and developed by Merck in USA.
Australia's contribution was an April study that showed ivermectin can kill the virus in vitro.
— Hoyt (@Hoytster) August 9, 2020
nice but don't forget us! Our Japanese group has developed a large number of desulfonylative cross couplings (and more to come!).
— Cathleen Crudden (@cathleencrudden) May 17, 2019
https://twitter.com/yattypat/status/1185221976702406656
Hiroshima stands for the insanity of atomic war and the inconceivable suffering of its victims. FM @HeikoMaas commemorates the victims of the atomic bombs in #Hiroshima& #Nagasaki: We owe them our unwavering commitment to a world without nuclear weapons. https://t.co/CiW4jyXqhj pic.twitter.com/GvsL8CAiO2
— GermanForeignOffice (@GermanyDiplo) August 6, 2020
https://twitter.com/DeepTech_VC/status/1291643558097756160
Hazard definition and classification review. The Sendai Framework for Disaster Risk Reduction 2015–2030 (‘the Sendai Framework’) @emweeklyrpt @UNDRR @GermanyDiplo @parisreview @GOT7_Japan @BBCAfrica @CAgovernor @UNDRR @NYCMayor @FLGovOFFICIALS
— NEPTA (@Neptanow) August 2, 2020
https://twitter.com/UNDP/status/1277678237389291521
https://twitter.com/NielsAnnen/status/1255085306321219584
The Banque de France and the Bundesbank each employ more than 10,000 people, twice as many as the Bank of England or the Bank of Japan https://t.co/BMoNHcEtYk
— The Economist (@TheEconomist) February 25, 2020
The Banque de France and the Bundesbank each employ more than 10,000 people, twice as many as the Bank of England or the Bank of Japan https://t.co/ocejSrwjpY
— The Economist Data Team (@ECONdailycharts) February 24, 2020
Today's top news and research in systemic risk and central banking, brought to you by: @Bank_of_Japan_e @bankofengland @bundesbank @voxeu @TheEconomist @WSJ @economics
— Yale Program on Financial Stability (@YPFSatYale) March 13, 2020
https://twitter.com/laurajaitman/status/1051074471514189825
https://twitter.com/laurajaitman/status/1022187299772227585
Dino Kos, CLS’s Chief Regulatory Officer will moderate the Global Policy Roundtable: Cross-Border Regulation of New Technologies. The roundtable features policy leaders from CFTC, FCA, Bank of Japan, Autorité des marchés financiers (AMF) & Bundesbank. https://t.co/vXHVt0RFZ0 pic.twitter.com/huVJsyYgYp
— CLS (@CLSGroup) September 17, 2018
@Bundesbank set up Tokyo office in 1987 same year as Louvre Accord to manage exchange rates by keeping Japanese & German interest rates low https://t.co/Ue7Ztb8xlD
— UPIER (@UPIER_HERA) May 22, 2017
Bundesbank Head Cautions Japan http://t.co/PcBy7Ybo
— WSJ Central Banks (@WSJCentralBanks) January 22, 2013
Off to Fukuoka/Japan. Meeting of the G20 Finance Ministers and Central Bank Gouverneurs. @G20japan2019 @G20Japan @BMF_Bund pic.twitter.com/omfaDWFjez
— Wolfgang Schmidt (@W_Schmidt_) June 6, 2019
The sweet taste of multilateralism: @g20org in Japan. Here: Joint session of Sherpas and Finance Deputies ahead of the Leader’s summit in #Osaka. @BMF_Bund pic.twitter.com/mmunAMQlSX
— Wolfgang Schmidt (@W_Schmidt_) June 27, 2019
https://twitter.com/GTAI_com/status/1207946301377257472
Omedetoooooo gozaimasu! Congratiulations @expo2025_japan! And see you first at the #GermanPavilion @expo2020dubai. You are very much welcome – yokoso! #expo2020dubai #expo2020 #expo2020germany #DeutscherPavillon #Weltausstellung #Dubai #Bmwi_bund #CAMPUSGERMANY #OSAKA2025 https://t.co/nJamZhCdZW
— expo2020germany (@expo2020germany) November 29, 2018
Just landed in Japan, a particularly interesting country for Germany with a similar industrial base. Eager to find out how Japan embarks on #digitaltransformation and #industry40. @GERonEconomy @BMWi_Bund @DoroBaer pic.twitter.com/x6MtFmXday
— Hinrich Thoelken (@GERDigitalEnvoy) November 19, 2018
https://twitter.com/GERonEconomy/status/1067755263594299393
A showcase for the technological leadership of @Daimler Trucks in #eMobility: Head of #Daimler Trucks Asia Hartmut Schick welcomed Federal German Minister for Economic Affairs @peteraltmaier @BMWi_Bund at the @FusoOfficial truck plant in Kawasaki, Japan. #eFUSO #eCanter #eTruck pic.twitter.com/3LFY8kiaVL
— Daimler Trucks & Buses (@DaimlerTruckBus) November 2, 2018
The panel discussion showed that #cooperation between countries on #hydrogen development is necessary. Now, presenters will show some examples of cooperation between #Germany and partner countries #SouthAfrica, #Japan and #UAE. @BMWi_Bund @AgoraEW @giz_gmbh @Navigant pic.twitter.com/xy7O7VXFyD
— Secretariat of the RSA-DE Energy Partnership (@Energy_RSA_DE) April 8, 2019
https://twitter.com/Total/status/1181909826076590081
Rainer Baake @Bmwi_bund visits Japan for @G7 energy ministers meeting.
See our japanese info on german #renewables: https://t.co/OxFFn8MmtQ— Agentur für Erneuerbare Energien e.V. (@RenewsTweet) April 29, 2016
Schlechte Nachricht für #Algorithmuskontrolle. USA u. Japan wollen Offenlegung durch Handelsvertrag verhindern. Muss rote Linie für @EU_Commission in #WTO #ecommerce Verhandlungen sein. @MiiBlinn @vzbv @beuc @BMWi_Bund https://t.co/kJwtTrdfPa
— Jonathan Maier (@JonathanTMaier) July 31, 2019
